Navigation Links
Amicus Therapeutics Announces Third Quarter 2008 Financial Results
Date:11/3/2008

Operating

Expenses:

Research and

development 7,537 8,200 21,404 23,989 113,867

General and

administrative 3,954 4,371 9,994 14,676 52,745

Impairment of

leasehold

improvements - - - - 1,030

Depreciation and

amortization 315 382 924 1,036 3,829

In-process

research and

development - - - - 418

Total

operating

expenses 11,806 12,953 32,322 39,701 171,889

Loss from

operations (11,806) (9,300) (32,322) (29,079) (159,485)

Other income

(expenses):

Interest

income 1,593 1,019 3,346 4,053 11,993

Interest

expense (90) (49) (269) (179) (1,608)

Change in

fair value

of warrant

liability - - (149) - (454)

Other expense - - - - (1,180)

Loss before

tax benefit (10,303) (8,330) (29,394) (25,205) (150,734)

(Provision

for)/benefit

from income

taxes - 150 - - 695

Net loss (10,303) (8,180) (29,394) (25,205) (150,039)

Deemed

dividend - - - - (19,424)

Preferred

stock

accretion - - (351) - (802)

Net loss

attributable

to common

stockholders $(10,303) $(8,180) $(29,745) $(25,205) $(170,265)

Net loss

attributable

to common

stockholders

per common

share - basic

and di
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
2. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
3. Amicus Therapeutics Opens Research Facility in San Diego
4. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
5. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
6. Amicus Therapeutics Announces First Quarter 2008 Financial Results
7. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015 IDEXX Laboratories, ... than 8,000 clinics have submitted over 100,000 specimens to ... in just the first 10 days since the breakthrough ... disease (CKD) is a leading cause of suffering and ... submitted specimens are consistent with generally accepted kidney disease ...
(Date:7/26/2015)... ... July 26, 2015 , ... Maine Standards Company, LLC ... linearity test kit. The VALIDATE® ANEMIA kit contains Ferritin, Folate, and Vitamin B12 ... the CLSI recommended “equal delta” method for linearity testing and is liquid, ready-to-use. ...
(Date:7/24/2015)... 2015 Ryan & Maniskas, LLP that ... District Court for the Northern District of California ... purchased the common stock of Avalanche Biotechnologies, Inc. ("Avalanche" or ... and June 15, 2015, inclusive (the "Class Period"). ... the Court for appointment as a lead plaintiff of the ...
(Date:7/24/2015)... , July 24, 2015 Equity ... PDL BioPharma Inc. (NASDAQ: PDLI ), Arena Pharmaceuticals ... STEM ), Northwest Biotherapeutics Inc. (NASDAQ: NWBO ), ... research report on PDL BioPharma can be accessed at ... NASDAQ Composite ended at 5,146.41, down 0.49%, the Dow ...
Breaking Biology Technology:Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 4Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 5Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5
... Feb. 13 Ferring Pharmaceuticals has,launched the ... for fundamental fertility and gynaecology research. This ... individual researchers,or research units/departments with the first ... 2010., Professor Paul Devroey, Free University ...
... in Interference, SAN DIEGO, Feb. 13 ... on the treatment of cardiac,arrhythmias, announced today that ... declared a patent interference between a patent,application exclusively ... Technologies Inc. A patent interference is an administrative,proceeding ...
... Feb. 13 Neogen Corporation,(Nasdaq: NEOG ) ... the dairy,industry to include the quickest test available ... dairy antibiotics is used to treat,bovine mastitis, and ... dairy antibiotic test for tetracyclines,complements the company,s widely ...
Cached Biology Technology:Launch of New, Prestigious Infertility and Gynaecology Research GrAnt (FRIGGA) 2United States Patent Office Grants CryoCor's Request for Patent Interference 2United States Patent Office Grants CryoCor's Request for Patent Interference 3Neogen Launches Quickest Test Available for Tetracyclines in Milk 2
(Date:6/29/2015)... DUBLIN , June 24, 2015 ... the addition of the "Latin America Biomedical Sensors ... to their offering. The Latin America Biomedical ... at a CAGR of 2.04% over the period 2014-2020 ... that are adaptable to the genetic formulation of each ...
(Date:6/25/2015)... CITY , June 25, 2015  Imagine a ... steps toward a healthier, happier life. That,s exactly what ... designed to do. The cutting-edge, portable health program provides ... real-life solutions to help improve your lifestyle and nutrition. ... awards dinner and gala Wednesday night, USANA,s THA was ...
(Date:6/24/2015)... YORK , June 24, 2015 This ... market, over the next six years. It contains an ... the industry, along with their impact from the short, ... It also discusses the industry, market, and technology trends ... that the need of concerned authorities to efficiently manage ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... Genetics may play a role in how people,s taste ... taste preferences, according to Penn State food scientists. These ... drink companies will need a range of artificial sweeteners ... differences in how people respond to tastes of foods," ...
... a dented can or a chopped-up piece of paper into ... study in the Journal of Consumer Research that ... are still recyclable, the likelihood of a consumer recycling a ... by the extent to which it has been distorted during ...
... to become big business in the baking aisles of all the ... prettier and some say tastier and cleaner-breaking than the traditional brown ... Nottingham, we know what caused the eggs in some breeds to ... published in the journal, PLOS ONE , the team from ...
Cached Biology News:Multiple genes manage how people taste sweeteners 2Landfill nation: What makes consumers less likely to recycle? 2Unscrambling the genetics of the chicken's 'blue' egg 2
... power of your ValveBank system! Program your ... computer running Windows 98, 2000, XP using graphic ... disk, print out program listings, then download your ... step., EasyCode is used for programming before -- ...
... DNA Ligase catalyzes the formation of phosphodiester ... double-stranded DNAs with 3' hydroxyl and 5' ... buffer optimizes ligation which can be performed ... are not substrates for this enzyme. ...
... is a major step forward in ... handling system - with one universal ... modules. All five single channel and ... one handle. The lightweight handle is ...
alpha-N-Catenin Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: